摘要:
An automated instrument and method for nucleic acid analysis is provided. The automated instrument is an integrated system including a sample processing station, a first reaction module, a second reaction module, a detection module and a control module for performing homogenous screening of broad specificity and multi-detection reactions on a nucleic acid test sample. The nucleic acid analysis performed in the instrument includes the steps of conducting a first test reaction using a low detection format, and if necessary, a selected second test reaction using a high detection format, detecting signals generated from the test reactions and processing signal data in a control module.
摘要:
The present invention provides for compositions and methods for serological immunoassay for the detection of Lyme disease infection using recombinant P37/FlaA protein antigen and methods for producing such protein antigen.
摘要:
The present invention is directed to sample test cards having an increased sample well capacity for analyzing biological or other test samples. In one embodiment, the sample test cards of the present invention comprise one or more fluid over-flow reservoirs, wherein the over-flow reservoirs are operatively connected to a distribution channel by a fluid over-flow channel. In another embodiment, the sample test cards may comprise a plurality of flow reservoirs operable to trap air thereby reducing and/or preventing well-to-well contamination. The test card of this invention may comprise from 80 to 140 individual sample wells, for example, in a test card sample test cards of the present invention have a generally rectangular shape sample test card having dimensions of from about 90 to about 95 mm in width, from about 55 to about 60 mm in height and from about 4 to about 5 mm in thickness.
摘要:
The invention relates to a method for the mass spectrometry-based detection of at least one marker of at least one mechanism of resistance to at least one antimicrobial agent, for at least one microorganism included in a sample. The method is characterised in that the antimicrobial agent is a cephalosporin, and said resistance markers are proteins or peptides. Preferably, the proteins or peptides are proteins of the aforementioned microorganism.